Innovative technologies are at the heart of the IMSR research activity, often integrated into comprehensive systems science and biology approaches to important clinical questions in metabolic, endocrine and reproductive disease.
Our principal investigators employ all elements of the translational cascade, with a combination of in vitro and in vivo models, human in vivo physiology, innovative metabolome and in vivo imaging approaches, experimental medicine studies and clinical trials. IMSR investigators drive core components of the Centre of Membrane Proteins and Receptors (COMPARE).
We utilise unique technology platforms for our frontier-pushing research:
Our research further benefits from the Next Generation Sequencing Core Facility, with major server capacity by the University of Birmingham BlueBEAR core.